CLOV — Clover Health Investments, Corp. stock price, charts and financials

QT73Clover Health Investments, Corp.

Clover Health Investments, Corp. (NASDAQ: CLOV) is a Healthcare company in the Medical - Healthcare Plans industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
4.63
-0.13-2.63%
OverviewShort InterestFilings
CLOVQT73Clover Health Investments, Corp.·NASDAQ
4.63-2.63%
TA
Loading chart...
Signal & projected range
Earnings big beat — drift (PEAD)Historical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Premium shows the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands ofhistorical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
ALHC-4.07%$13.79OSCR+1.29%$28.26MOH+0.97%$198.35CNC+0.81%$66.31HUM+0.11%$385.41CI-1.19%$279.13ELV+0.78%$397.29CVS-0.99%$94.75
Snapshot
Index-P/E-EPS (ttm)-0.11Insider Own-Shs Outstand518.26MPerf Week14.15%
Market Cap2.47BForward P/E46.86EPS next Y0.10Insider Trans-0.42%Shs Float408.51MPerf Month1.71%
Enterprise Value2.27BPEG5.86EPS next Q-Inst Own-Short Float7.04%Perf Quarter68.79%
Income-18.26MP/S1.00EPS this Y162.09%Inst Trans-Short Ratio3.71Perf Half Y133.33%
Sales2.48BP/B6.63EPS next Y48.73%ROA-2.55%Short Interest28.75MPerf YTD102.55%
Book/sh-P/C13.49EPS next 5Y42.29%ROE-5.38%52W High5.44 -14.85%Perf Year110.62%
Cash/sh-P/FCF13.61EPS past 3/5Y-ROIC-4.63%52W Low1.54 201.27%Perf 3Y277.78%
Dividend Est.-EV/EBITDA-Sales past 3/5Y20.60% 23.38%Gross Margin18.57%Volatility6.93% 5.73%Perf 5Y-41.02%
Dividend TTM-EV/Sales0.92EPS Y/Y TTM-25.28%Oper. Margin-0.74%ATR (14)0.30Perf 10Y-
Dividend Ex-DateAug 23, 2021Quick Ratio1.50Sales Y/Y TTM61.34%Profit Margin-0.74%RSI (14)56.18Recom3.22
Dividend Gr. 3/5Y-Current Ratio1.50EPS Q/Q40.00%SMA206.45%Beta2.49Target Price5.25
Payout0.00%Debt/Eq0.00Sales Q/Q62.12%SMA503.45%Rel Volume1.00Prev Close4.76
Employees724LT Debt/Eq0.01EarningsNov 04SMA20057.60%Avg Volume7.42MPrice4.63
IPO DateJun 12, 2020Option/ShortYes / YesEPS/Sales Surpr.0.93% 4.80%Net Debt/EBITDA12.08Volume7,396,593Change-2.63%
Analyst Ratings
DateActionAnalystRatingTarget
Aug-06-26ReiteratedUBSNeutral$4.75 → $5.00
Jul-21-26ReiteratedCanaccord GenuityBuy$4.20 → $5.50
Jun-11-26ReiteratedUBSNeutral$4.75
Jun-04-26ReiteratedCanaccord GenuityBuy$2.50 → $4.20
Oct-21-25ReiteratedLeerink Partners$3.00
Dec-17-24InitiatedCraig-HallumBuy$6.00
Aug-06-24ReiteratedCanaccord GenuityBuy$2.50
Nov-16-22ReiteratedCitigroupNeutral$1.80
Feb-02-22UpgradeCowen & Co.Underperform → Market Perform
Jan-07-22DowngradeCredit SuisseNeutral → Underperform
Latest News
Aug-06-26
Aug-06-2603:04PM
UBS Maintains Neutral on Clover Health Investments, Raises Price Target to $5Benzinga
Aug-05-26
Aug-05-2608:50PM
Clover Health Investments, Corp. (CLOV) Q2 2026 Earnings Call Transcriptseekingalpha.com
08:04PM
Clover Health Investments Q2 Earnings Call Highlightsmarketbeat.com
04:05PM
Clover Health Reports Second Quarter 2026 Resultsglobenewswire.com
Aug-03-26
Aug-03-2607:30AM
Is Clover Health Finally Turning the Corner?247wallst.com
Jul-31-26
Jul-31-2608:21AM
Clover Health's CEO Just Sold 62,711 Shares for Tax Withholding. The Bigger News Comes Next Week.fool.com
Jul-28-26
Jul-28-2604:02PM
'Trump Administration To End Medicare Drug Plan Subsidy; Program That Held Down Premiums Not Renewed For 2027, Resulting In Higher Costs For Some Seniors' - WSJ ExclusiveBenzinga
Jul-22-26
Jul-22-2604:05PM
Clover Health to Participate in Upcoming Canaccord Genuity 46th Annual Growth Conferenceglobenewswire.com
Jul-17-26
Jul-17-2604:49PM
Clover Health says employee accounts accessed in cyber incidentreuters.com
04:35PM
Clover Health Investments Reports Anomalous Login Activity On Information Systems On July 4, 2026; Does Not Expect Material Impact From Incident; Threat Actor Accessed Three Non-Managerial Employee Accounts Via Social Engineering; Accessed Accounts Had Member Data But No Access To Financial Or Claims Systems; Co. Believes Unauthorized Access Was Contained And TerminatedBenzinga
Jul-09-26
Jul-09-2604:05PM
Clover Health to Report Second Quarter 2026 Financial Results on August 5, 2026globenewswire.com
Jul-07-26
Jul-07-2608:30AM
Clinical Excellence in Continuity of Care: Counterpart Assistant (CA) Use Associated With Stronger Performance Across Transitions of Care Measures and Post-Hospitalization Follow-Upglobenewswire.com
Jul-06-26
Jul-06-2608:32PM
Clover Health's CEO Sold Company Shares Worth $1.7 Million. Here's What That Means for Investors.fool.com
10:02AM
Insurer Elevance Seeks Recalculated Medicare Star Rating in LawsuitBenzinga
Jun-27-26
Jun-27-2601:13PM
A Clover Health Director Sold Over 67,000 Company Shares. Here's a Closer Look at the Transaction.fool.com
Company

Clover Health Investments, Corp. is a U.S.-based firm specializing in Medicare Advantage insurance. The company leverages its proprietary software platform, the Clover Assistant, to provide both Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) health plans for individuals eligible for Medicare. In addition to its insurance operations, Clover Health also engages in non-insurance-related business ventures. The company was established in 2014 and its main office is located in Franklin, Tennessee.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue2,4771,9241,371——————
Cost of Goods Sold Incl. D&A2,0161,5681,006——————
Gross Profit460356365——————
Selling, General and Administrative Excl. Other213176409——————
Research and Development
000——————
Other Operating Expense2662652——————
Operating Income-18-86-46——————
Interest Expense
000——————
Unusual Expense
—————————
Non-Operating Income (Expense)00-1——————
Net Income Before Taxes-18-86-46——————
Income Taxes
000——————
Consolidated Net Income-18-86-43——————
Net Income From Continuing Operations-18-86-46——————
Net Income-18-86-43——————
EPS (Recurring)-0.04-0.17-0.09——————
EPS (Basic, Before Extraordinaries)-0.04-0.17-0.09——————
EPS (Diluted)-0.04-0.17-0.09——————
EBITDA-16-84-45——————
Other After Tax Adjustments
—————————
Stock Option Compensation Expense
—————————
Price To Earnings Ratio
—————————
Price To Sales Ratio0.980.631.13——————
Gross Margin18.5718.5026.62——————
Operating Margin-0.73-4.47-3.36——————
Net Margin-0.73-4.47-3.14——————
Shares Outstanding524517490——————
Market Capitalization2,4291,2151,544——————
Operating Lease Expense
—————————
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
$5.97$4.76$3.55$2.35$1.14● Close Price0.00M0.63M1.25M1.88M2.50MUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Soares KarenChief Legal OfficerJul 20 '26Sale4.5151,700233,1671,505,522Jul 20
Reynoso Jamie L.CEO, Medicare AdvantageJul 17 '26Sale4.534,83921,9212,814,640Jul 17
Reynoso Jamie L.CEO, Medicare AdvantageJul 15 '26Sale4.6713,11961,2662,819,479Jul 16
Soares KarenChief Legal OfficerJul 15 '26Sale4.6710,51949,1241,557,222Jul 16
THORNTON JOSEPH CLAYInterim CFOJul 15 '26Sale4.674,63021,6221,212,954Jul 16
Wai ConradCEO, Counterpart HealthJul 15 '26Sale4.6724,215113,0841,145,699Jul 16
Toy AndrewChief Executive OfficerJul 15 '26Sale4.6762,711292,8609,547,114Jul 16
Reynoso Jamie L.CEO, Medicare AdvantageJul 08 '26Sale4.682,38411,1572,832,598Jul 09
Reynoso Jamie L.CEO, Medicare AdvantageJul 06 '26Sale5.266,22932,7652,834,982Jul 06
Toy AndrewChief Executive OfficerJul 01 '26Sale5.32313,4761,667,6929,609,825Jul 01
Reynoso Jamie L.CEO, Medicare AdvantageJun 17 '26Sale4.782,36011,2812,841,211Jun 18
OLDAKOWSKI JOSEPH FRANKVP OF FINANCE AND CONTROLLERJun 16 '26Sale4.8612,10258,816299,067Jun 17
Soares KarenChief Legal OfficerJun 15 '26Sale4.614,68121,5791,567,741Jun 16
Reynoso Jamie L.CEO, Medicare AdvantageJun 15 '26Sale4.616,35029,2742,843,571Jun 16
Reynoso Jamie L.CEO, Medicare AdvantageJun 11 '26Sale4.917,28935,7892,849,921Jun 11
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.